An interventional study of Superficial Cervical Plexus Block (SCP) block and Local site infiltration in Pacemaker Insertion, Regional Block and Pain, sponsored by Mayo Clinic. Terminated at 1 site in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-02-01.
Sponsored by Mayo Clinic · Not applicable, Interventional, and Other
The purpose of this study is to investigate clinical outcomes from two current standard of care pain control procedures performed for patients undergoing pacemaker insertion.
Mayo Clinic is the lead sponsor of 3,218 studies on the registry; 670 are open to participants now.
Of its 445 completed or terminated interventional studies of FDA-regulated products, 313 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Superficial Cervical Plexus Block (SCP) block
Procedure: Local site infiltration
SCP block using 10-15ml of 1% Ropivacaine
Local site infiltration using 2% lidocaine
To decrease opioid requirements after Pacemaker insertion
Time frame: first 24 hrs post pacemaker insertion
This study is terminated, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mayo Clinic